ACADIA Pharmaceuticals Inc. vs Logitech International SA — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Logitech International SA trades at $105.25 (market cap $14.96B). The key difference: Logitech International SA is far larger — about 3× ACADIA Pharmaceuticals Inc.'s market cap, and Logitech International SA pays a 1.64% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | LOGI | |
|---|---|---|
Market Cap | $5.07B | $14.96B |
Sector | Health | Technology |
52-Week High | $29.41 | $126.69 |
52-Week Low | $20.06 | $85.84 |
Enterprise Value | $4.19B | $13.30B |
Dividend Yield | — | 1.64% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →